3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Motor Activity
126
Breast Neoplasms
78
Neoplasms
48
Prostatic Neoplasms
19
Fatigue
16
Obesity
14
Colorectal Neoplasms
13
Lung Neoplasms
11
Polycystic Ovary Syndrome
10
Colonic Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Head and Neck Neoplasms
7
Weight Loss
6
Ovarian Neoplasms
6
Rectal Neoplasms
5
Multiple Myeloma
5
Lymphedema
5
Leukemia
5
Inflammation
5
Pancreatic Neoplasms
4
Overweight
4
Multiple Endocrine Neoplasia Type 1
4
Lymphoma
4
Leukemia, Myeloid, Acute
4
Insulin Resistance
4
Depression
4
Cognitive Dysfunction
4
Brain Neoplasms
4
Stomach Neoplasms
3
Peripheral Nervous System Diseases
3
Interventions
Gemcitabine
35
Cisplatin
21
Capecitabine
17
Oxaliplatin
16
Leucovorin
11
Fluorouracil
11
pembrolizumab
8
S 1 (combination)
8
Nivolumab
6
tremelimumab
5
durvalumab
5
Bevacizumab
5
lenvatinib
4
Irinotecan
4
trametinib
3
titanium silicide
3
atezolizumab
3
Radiofrequency Ablation
3
zanidatamab
2
vandetanib
2
irinotecan sucrosofate
2
derazantinib
2
camrelizumab
2
binimetinib
2
apatinib
2
Trastuzumab
2
Tegafur
2
Radiotherapy
2
Panitumumab
2
Ipilimumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Biliary Tract Neoplasms
×
Exercise
×
Clear all
NCT05044065
2025-08-27
PREV-Ex
Karolinska Institutet
Phase NA
Completed
52 enrolled